$1.03
-0.07-6.36%
In chiusura: -
$1.01
-0.02-1.94%
Pre-mercato: Nov 14, 6:41 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading NovaBay Pharmaceuticals. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni NovaBay Pharmaceuticals.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli NovaBay Pharmaceuticals Inc addetti ai lavori?
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
Non ci sono stati acquisti o vendite da parte di Insider negli ultimi 90 giorni.
Statistiche sulla proprietà per NovaBay Pharmaceuticals Inc
Numero di azioni emesse
126.011M
Azioni possedute dagli insider
2.119M
Percentuale posseduta dagli Insider
35.3%
Azioni possedute dagli investitori istituzionali
51.816K
Percentuale posseduta dagli investitori istituzionali
0.86%
Apr 15, 2025 | 10% OWNER | 28.73K | $0.56 | $15.97K | BUY | 2.90% | 1.02M | Apr 02 - Apr 08 | ||
Apr 15, 2025 | 10% OWNER | 123.36K | $0.60 | $74.52K | BUY | 14.21% | 991.57K | Mar 26 - Apr 01 | ||
Apr 15, 2025 | 10% OWNER | 49.93K | $0.62 | $30.72K | BUY | 6.10% | 868.20K | Mar 18 - Mar 25 | ||
Apr 15, 2025 | 10% OWNER | 64.17K | $0.62 | $39.50K | BUY | 8.51% | 818.28K | Mar 10 - Mar 18 | ||
Apr 15, 2025 | 10% OWNER | 48.93K | $0.61 | $29.86K | BUY | 6.94% | 754.10K | Feb 25 - Mar 07 | ||
Apr 15, 2025 | 10% OWNER | 84.49K | $0.66 | $55.53K | BUY | 13.61% | 705.17K | Feb 03 - Feb 24 | ||
Apr 15, 2025 | 10% OWNER | 102.39K | $0.66 | $67.70K | BUY | 19.75% | 620.68K | Jan 27 - Jan 31 | ||
Dec 07, 2022 | CHIEF PRODUCT OFFICER | -1.00 | $1.81 | -$1.81 | SELL | -100.00% | 0.00 | Dec 06 | ||
Dec 07, 2022 | PRESIDENT, DERMADOCTOR, LLC | -1.00 | $1.81 | -$1.81 | SELL | -100.00% | 0.00 | Dec 06 | ||
Nov 23, 2022 | CHIEF PRODUCT OFFICER | -5.96K | $2.10 | -$12.55K | SELL | -100.00% | 0.00 | Nov 21 | ||
Nov 23, 2022 | PRESIDENT, DERMADOCTOR, LLC | -5.96K | $2.10 | -$12.55K | SELL | -100.00% | 0.00 | Nov 21 | ||
Sep 16, 2022 | CEO, GC AND DIRECTOR | 10.00K | $0.15 | $1.50K | BUY | 13.67% | 83.17K | Sep 14 | ||
Sep 16, 2022 | PRESIDENT, DERMADOCTOR, LLC | -291.37K | $0.16 | -$46.09K | SELL | -58.27% | 208.63K | Sep 14 | ||
Sep 16, 2022 | CHIEF PRODUCT OFFICER | -291.37K | $0.16 | -$46.09K | SELL | -58.27% | 208.63K | Sep 14 | ||
Dec 07, 2021 | PRESIDENT, DERMADOCTOR, LLC | 101.65K | $0.46 | $47.01K | BUY | 25.52% | 500.00K | Dec 03 | ||
Dec 07, 2021 | CHIEF PRODUCT OFFICER | 101.65K | $0.46 | $47.01K | BUY | 25.52% | 500.00K | Dec 03 | ||
Dec 06, 2021 | CEO, GC AND DIRECTOR | 69.77K | $0.43 | $30.00K | BUY | 2048.96% | 73.17K | Dec 06 | ||
Dec 06, 2021 | PRESIDENT, DERMADOCTOR, LLC | 262.37K | $0.48 | $124.89K | BUY | 192.95% | 398.35K | Dec 02 | ||
Dec 06, 2021 | CHIEF PRODUCT OFFICER | 262.37K | $0.48 | $124.89K | BUY | 192.95% | 398.35K | Dec 02 | ||
Dec 06, 2021 | CFO | 45.45K | $0.44 | $20.00K | BUY | 55.43% | 127.46K | Dec 03 - Dec 06 | ||
Dec 03, 2021 | CHIEF PRODUCT OFFICER | 14.85K | $0.49 | $7.28K | BUY | 12.26% | 135.98K | Dec 01 | ||
Dec 03, 2021 | PRESIDENT, DERMADOCTOR, LLC | 14.85K | $0.49 | $7.28K | BUY | 12.26% | 135.98K | Dec 01 | ||
Dec 02, 2021 | PRESIDENT, DERMADOCTOR, LLC | 30.00K | $0.46 | $13.80K | BUY | 32.92% | 121.13K | Nov 30 | ||
Dec 02, 2021 | CHIEF PRODUCT OFFICER | 30.00K | $0.46 | $13.80K | BUY | 32.92% | 121.13K | Nov 30 | ||
Nov 24, 2021 | CHIEF PRODUCT OFFICER | 91.13K | $0.46 | $41.87K | BUY | ∞ | 91.13K | Nov 22 - Nov 23 | ||
Nov 24, 2021 | PRESIDENT, DERMADOCTOR, LLC | 91.13K | $0.46 | $41.87K | BUY | ∞ | 91.13K | Nov 22 - Nov 23 | ||
Aug 19, 2020 | — | 0.00 | $0.83 | -$21.00K | GRANT OR AWARD | 0.00% | 0.00 | Aug 17 | ||
Aug 04, 2020 | — | -1.30M | $1.23 | -$1.60M | SELL | -24.56% | 4.00M | Aug 01 | ||
Jun 13, 2019 | 10% OWNER | -380.95K | $3.84 | -$1.46M | SELL | -6.70% | 5.30M | Jun 11 | ||
Jun 13, 2019 | 10% OWNER | -24.33K | $4.04 | -$98.28K | SELL | -0.47% | 5.19M | Jun 11 | ||
Jun 13, 2019 | DIRECTOR | -63.49K | $2.53 | -$160.79K | SELL | -100.00% | 0.00 | Jun 10 - Jun 11 | ||
Aug 21, 2015 | CHIEF EXECUTIVE OFFICER | 12.00K | $0.47 | $5.64K | BUY | ∞ | 12.00K | Aug 19 - Aug 20 | ||
Mar 05, 2015 | DIRECTOR | 166.67K | $0.60 | $100.00K | BUY | 559.28% | 196.47K | Mar 03 | ||
Mar 05, 2015 | CHIEF EXECUTIVE OFFICER | 166.67K | $0.60 | $100.00K | BUY | 5.17% | 3.39M | Mar 03 | ||
Mar 05, 2015 | 10% OWNER | 2.59M | $0.60 | $1.55M | BUY | 36.97% | 9.60M | Mar 03 | ||
Dec 16, 2014 | SVP, OPHTHALMIC PRODUCT DEVT. | 10.00K | $0.66 | $6.60K | BUY | 76.92% | 23.00K | Dec 12 | ||
Dec 15, 2014 | CFO | 10.00K | $0.68 | $6.80K | BUY | 17.18% | 68.21K | Dec 12 | ||
Dec 15, 2014 | CHIEF EXECUTIVE OFFICER | 50.00K | $0.65 | $32.50K | BUY | ∞ | 0.00 | Dec 12 | ||
Dec 11, 2014 | CFO | 10.00K | $0.67 | $6.70K | BUY | 20.74% | 58.21K | Dec 09 | ||
Dec 11, 2014 | CHIEF EXECUTIVE OFFICER | 20.00K | $0.60 | $12.00K | BUY | 0.63% | 3.17M | Dec 11 | ||
Dec 08, 2014 | CHIEF EXECUTIVE OFFICER | 25.00K | $0.65 | $16.25K | BUY | 0.80% | 3.15M | Dec 05 | ||
Dec 04, 2014 | CHIEF EXECUTIVE OFFICER | 18.00K | $0.71 | $12.78K | BUY | 0.58% | 3.13M | Dec 02 | ||
Dec 04, 2014 | DIRECTOR | -20.00K | $0.70 | -$14.00K | SELL | -100.00% | 0.00 | Dec 02 | ||
Dec 03, 2014 | DIRECTOR | -10.00K | $0.69 | -$6.90K | SELL | -4.47% | 213.68K | Dec 01 | ||
Jun 05, 2014 | DIRECTOR | 4.80K | $0.89 | $4.27K | BUY | 19.20% | 29.80K | Jun 04 | ||
May 21, 2014 | DIRECTOR | 25.00K | $0.88 | $22.00K | BUY | ∞ | 25.00K | May 19 | ||
May 14, 2014 | 10% OWNER | 65.06K | $0.99 | $64.41K | BUY | 0.86% | 7.61M | May 13 | ||
May 14, 2014 | 10% OWNER | 116.11K | $0.99 | $114.95K | BUY | 1.56% | 7.55M | May 12 | ||
May 14, 2014 | 10% OWNER | 318.83K | $0.99 | $315.64K | BUY | 4.48% | 7.43M | May 09 | ||
Dec 04, 2013 | 10% OWNER | 5.00M | $1.14 | $5.70M | BUY | 236.54% | 7.11M | Dec 02 | ||
Dec 04, 2013 | 10% OWNER | 5.00M | $1.14 | $5.70M | BUY | 249.29% | 7.01M | Dec 02 | ||
Dec 04, 2013 | 10% OWNER | 5.00M | $1.14 | $5.70M | BUY | 249.29% | 7.01M | Dec 02 | ||
Dec 02, 2013 | 10% OWNER | 112.07K | $1.02 | $110.32K | BUY | ∞ | 108.16K | Jul 22 - Nov 14 | ||
Dec 02, 2013 | 10% OWNER | -120.00K | $1.87 | -$224.99K | SELL | -100.00% | 0.00 | Sep 20 | ||
Jan 03, 2013 | 10% OWNER | 120.00K | $1.20 | $144.00K | BUY | 6.00% | 2.12M | Dec 11 | ||
Jan 02, 2013 | 10% OWNER | 1.20M | $1.25 | $1.50M | BUY | 150.00% | 2.00M | Oct 31 | ||
Jan 02, 2013 | 10% OWNER | 800.00K | $1.25 | $1.00M | BUY | ∞ | 800.00K | Sep 13 | ||
Dec 10, 2012 | SVP, OPHTHALMIC PRODUCT DEVT. | 10.00K | $1.24 | $12.40K | BUY | 83.33% | 22.00K | Dec 06 | ||
Dec 10, 2012 | CFO | 10.00K | $1.24 | $12.40K | BUY | 18.57% | 63.85K | Dec 06 | ||
Dec 10, 2012 | CHIEF EXECUTIVE OFFICER | 20.00K | $1.24 | $24.80K | BUY | 0.63% | 3.22M | Dec 06 | ||
Nov 20, 2012 | 10% OWNER | 1.20M | $1.25 | $1.50M | BUY | 150.00% | 2.00M | Oct 31 | ||
Nov 05, 2012 | 10% OWNER | 1.20M | $1.25 | $1.50M | BUY | 150.00% | 2.00M | Oct 31 | ||
May 31, 2012 | CFO | 10.00K | $0.94 | $9.36K | BUY | 21.05% | 57.50K | May 30 | ||
May 30, 2012 | CHIEF EXECUTIVE OFFICER | 6.00K | $0.96 | $5.76K | BUY | 0.19% | 3.15M | May 29 | ||
May 29, 2012 | CHIEF EXECUTIVE OFFICER | 3.50K | $0.99 | $3.46K | BUY | 0.11% | 3.15M | May 25 | ||
Sep 13, 2011 | DIRECTOR | 3.00K | $0.84 | $2.52K | BUY | 24.72% | 15.14K | Sep 12 | ||
Aug 29, 2011 | CFO | 3.50K | $0.86 | $3.01K | BUY | 87.50% | 7.50K | Aug 26 | ||
Aug 16, 2011 | CHIEF EXECUTIVE OFFICER | 10.00K | $0.85 | $8.50K | BUY | 0.32% | 3.14M | Aug 16 | ||
Aug 16, 2011 | DIRECTOR | 5.00K | $0.85 | $4.24K | BUY | 1.59% | 319.91K | Aug 15 | ||
May 31, 2011 | CHIEF EXECUTIVE OFFICER | 500.00 | $1.59 | $797.25 | BUY | 0.02% | 3.13M | May 27 | ||
May 31, 2011 | VP RESEARCH AND DEVELOPMENT | 1.00K | $1.64 | $1.64K | BUY | 0.74% | 137.00K | May 27 | ||
May 27, 2011 | DIRECTOR | 6.20K | $1.65 | $10.22K | BUY | 16.23% | 44.39K | May 27 | ||
May 27, 2011 | CHIEF EXECUTIVE OFFICER | 1.00K | $1.60 | $1.60K | BUY | 0.03% | 3.13M | May 26 | ||
May 26, 2011 | CHIEF EXECUTIVE OFFICER | 2.55K | $1.71 | $4.37K | BUY | 0.08% | 3.13M | May 24 | ||
Aug 18, 2010 | DIRECTOR | -15.00K | $1.83 | -$27.45K | SELL | -55.28% | 12.14K | Aug 16 | ||
Aug 31, 2009 | DIRECTOR | 1.00K | $1.90 | $1.90K | BUY | 3.68% | 28.17K | Aug 31 | ||
Aug 28, 2009 | CHIEF EXECUTIVE OFFICER | 1.00K | $1.92 | $1.92K | BUY | 0.03% | 3.13M | Aug 28 | ||
Jun 15, 2009 | DIRECTOR | -25.00K | $2.33 | -$58.25K | SELL | -51.27% | 23.76K | Jun 11 | ||
Jun 15, 2009 | DIRECTOR | 25.00K | $2.33 | $58.25K | BUY | 169.76% | 39.73K | Jun 11 | ||
Dec 11, 2008 | CHIEF EXECUTIVE OFFICER | 500.00 | $1.14 | $570.00 | BUY | 0.02% | 3.13M | Dec 10 | ||
Sep 12, 2008 | DIRECTOR | 200.00 | $2.00 | $400.00 | BUY | 1.07% | 18.85K | Sep 12 | ||
Sep 12, 2008 | CHIEF EXECUTIVE OFFICER | 1.50K | $1.90 | $2.85K | BUY | 0.05% | 3.13M | Sep 11 - Sep 12 | ||
Sep 12, 2008 | VP RESEARCH AND DEVELOPMENT | 500.00 | $1.95 | $975.00 | BUY | 0.37% | 136.00K | Sep 11 | ||
Sep 12, 2008 | CFO | 2.00K | $1.92 | $3.84K | BUY | 100.00% | 4.00K | Sep 11 - Sep 12 | ||
Sep 02, 2008 | CHIEF EXECUTIVE OFFICER | 1.00K | $1.98 | $1.98K | BUY | 0.03% | 3.12M | Sep 02 | ||
Aug 20, 2008 | CHIEF EXECUTIVE OFFICER | 2.60K | $2.00 | $5.21K | BUY | 0.08% | 3.12M | Aug 19 - Aug 20 | ||
Mar 18, 2008 | VP, RESEARCH & DEV'T | 500.00 | $2.72 | $1.36K | BUY | 0.37% | 135.50K | Mar 14 | ||
Mar 18, 2008 | CHIEF FINANCIAL OFFICER | 2.00K | $2.70 | $5.40K | BUY | ∞ | 2.00K | Mar 14 | ||
Mar 18, 2008 | DIRECTOR | 3.00K | $2.75 | $8.25K | BUY | 2.01% | 152.14K | Mar 14 | ||
Mar 18, 2008 | DIRECTOR | 500.00 | $2.97 | $1.49K | BUY | 3.85% | 13.49K | Mar 14 | ||
Mar 18, 2008 | CHIEF EXECUTIVE OFFICER | 3.60K | $2.71 | $9.77K | BUY | 0.12% | 3.12M | Mar 14 | ||
Mar 17, 2008 | DIRECTOR | 2.50K | $2.43 | $6.07K | BUY | 1.26% | 200.25K | Mar 13 | ||
Oct 31, 2007 | DIRECTOR | 138.93K | $4.00 | $270.00K | BUY | 250.00% | 194.50K | Oct 31 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.